Skip to main navigation Skip to search Skip to main content

GRADE guidance 23: considering cost-effectiveness evidence in moving from evidence to health-related recommendations

  • Feng Xie
  • , Ian Shemilt
  • , Luke Vale
  • , Francis Ruiz
  • , Michael F. Drummond
  • , Joanne Lord
  • , Kirsten H. Herrmann
  • , María Ximena Rojas
  • , Yuan Zhang
  • , Carlos Canelo-Aybar
  • , Pablo Alonso-Coello
  • , Tatyana Shamliyan
  • , Holger J. Schünemann
  • McMaster University
  • Campbell & Cochrane Economics Methods Group
  • University College London
  • Newcastle University
  • London School of Hygiene and Tropical Medicine
  • University of York
  • University of Southampton
  • ResearchGCP
  • Research Institute of the Santa Creu i Sant Pau Hospital
  • Centro de Investigación Biomédicaen Red de Epidemiología y Salud Pública (CIBERESP)
  • American College of Physicians

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Background: This is the 23rd in a series of articles describing the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to grading the certainty of evidence and strength of recommendations for systematic reviews, health technology assessments, and clinical guideline development. Objectives: We outline how resource utilization and cost-effectiveness analyses are integrated into health-related recommendations, using the GRADE Evidence to Decision (EtD) frameworks. Study Design and Setting: Through iterative discussions and refinement, in-person, and online meetings, and through e-mail communication, we developed draft guidance to incorporate economic evidence in the formulation of health-related recommendations. We developed scenarios to operationalize the guidance. We presented a summary of the results to members of the GRADE Economic Evaluation Project Group. Results: We describe how to estimate the cost of preventing (or achieving) an event to inform assessments of cost-effectiveness of alternative treatments, when there are no published economic evaluations. Evidence profiles and Summary of Findings tables based on systematic reviews of cost-effectiveness analyses can be created to provide top-level summaries of results and quality of multiple published economic evaluations. We also describe how this information could be integrated in GRADE's EtD frameworks to inform health-related recommendations. Three scenarios representing various levels of available cost-effectiveness evidence were used to illustrate the integration process. Conclusion: This GRADE guidance provides practical information for presenting cost-effectiveness data and its integration in the development of health-related recommendations, using the EtD frameworks.

Original languageEnglish
Pages (from-to)135-144
Number of pages10
JournalJournal of Clinical Epidemiology
Volume162
DOIs
StatePublished - Oct 2023

Keywords

  • Cost-effectiveness analysis
  • Economic evaluation
  • Evidence to decision frameworks
  • GRADE
  • Guidelines
  • Systematic reviews

Fingerprint

Dive into the research topics of 'GRADE guidance 23: considering cost-effectiveness evidence in moving from evidence to health-related recommendations'. Together they form a unique fingerprint.

Cite this